Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (531-540 of 762) with videos related to

Pageof 77
Sort By:
Chemical Biology & Drug Design|November 16, 2006
Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonistsMinying Cai, Eva V Varga, Magda Stankova, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stabilityS A Thomas, T J Abbruscato, V S Hau, et al.
Molecular and Cellular Endocrinology|February 7, 1997
Characterisation of D117A and H260A mutations in the melanocortin 1 receptorH B Schiöth, R Muceniece, M Szardenings, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Fluorescent and lanthanide labeling for ligand screens, assays, and imagingJatinder S Josan, Channa R De Silva, Byunghee Yoo, et al.
Life Sciences|March 23, 1987
Differential structural requirements for the MSH and MCH activities of melanin concentrating hormoneM E Hadley, C Zechel, B C Wilkes, et al.
Peptides|November 26, 1999
The effect of halogenation on blood-brain barrier permeability of a novel peptide drugC L Gentry, R D Egleton, T Gillespie, et al.
International Journal of Peptide and Protein Research|July 1, 1996
Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptidesV Ramaswami, X Zhu, M Romanowski, et al.
Biopharmaceutics & Drug Disposition|April 1, 1997
Skin pigmentation and pharmacokinetics of melanotan-I in humansS O Ugwu, J Blanchard, R T Dorr, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 9, 2003
Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5P Grieco, P Balse-Srinivasan, G Han, et al.
Pageof 77

Showing results (531-540 of 762) with videos related to

Sort By:
Pageof 77
Chemical Biology & Drug Design|November 16, 2006
Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonistsMinying Cai, Eva V Varga, Magda Stankova, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stabilityS A Thomas, T J Abbruscato, V S Hau, et al.
Molecular and Cellular Endocrinology|February 7, 1997
Characterisation of D117A and H260A mutations in the melanocortin 1 receptorH B Schiöth, R Muceniece, M Szardenings, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Fluorescent and lanthanide labeling for ligand screens, assays, and imagingJatinder S Josan, Channa R De Silva, Byunghee Yoo, et al.
Life Sciences|March 23, 1987
Differential structural requirements for the MSH and MCH activities of melanin concentrating hormoneM E Hadley, C Zechel, B C Wilkes, et al.
Peptides|November 26, 1999
The effect of halogenation on blood-brain barrier permeability of a novel peptide drugC L Gentry, R D Egleton, T Gillespie, et al.
International Journal of Peptide and Protein Research|July 1, 1996
Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptidesV Ramaswami, X Zhu, M Romanowski, et al.
Biopharmaceutics & Drug Disposition|April 1, 1997
Skin pigmentation and pharmacokinetics of melanotan-I in humansS O Ugwu, J Blanchard, R T Dorr, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 9, 2003
Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5P Grieco, P Balse-Srinivasan, G Han, et al.
Pageof 77